Atlas Trials

A Study of SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLC

Clinical trial NCT06434740 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06434740
Sponsor
Sir Run Run Shaw Hospital
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small-Cell Lung Cancer
Start date
2024-06-01
Primary completion
2026-12-30
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.